ABOS

Acumen Pharmaceuticals, Inc.

3.76 USD
+0.36 (+10.59%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Acumen Pharmaceuticals, Inc. stock is up 18.61% since 30 days ago. The next earnings date is Aug 6, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 2 May’s closed higher than April. 100% of analysts rate it a buy.

About Acumen Pharmaceuticals, Inc.

Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage.